“blend-therapeutics” Archives

in
Entry Author Date Location
Tarveda Nabs $30M More as Versant Helps Fund Cancer Drug Push 02/02/17 Boston
With $163M Deal, Tarveda Revives Synta Pharma’s Cancer Drug Work 09/19/16 Boston
East Coast Biotech Roundup: Harvard’s Haul, Patent Fights, Padlock & More 03/24/16 Boston
Tarveda Formally Spins Out Placon to Advance Platinum Cancer Drugs 03/23/16 Boston
East Coast Biotech Roundup: Editas, Hep C, Akashi, Tarveda & More 01/29/16 Boston
Blend Rebrands as Tarveda, Raises $38M, and Spins Out Cancer Drug 01/27/16 Boston
Blend Therapeutics Taps Former Clinical Data Chief Fromkin As New CEO 04/13/15 Boston
East Coast Biotech Roundup: Pre-J.P. Morgan Preening Edition 01/09/15 Boston
With $21M, Retooled Blend Whips up Mini-Smart Bombs For Cancer 01/07/15 Boston
Blend Therapeutics Receives $21,000,000 New Financing Round 01/07/15 Boston
East Coast Biotech Roundup: Concert, Merrimack, Vertex, & More 05/02/14 Boston
Blend Therapeutics Obtains $999,999 New Funding Round 03/12/14 Boston
Blend Therapeutics Secures $5,000,000 New Financing Round 12/26/13 Boston
East Coast Life Sciences Roundup: Blend, Amicus, Vertex, & More 12/21/12 Boston
Boston News Roundup: Amazon, Akamai, Blend, MC10, & More 12/19/12 Boston
Blend Therapeutics Raises $16 Million to Fund Cancer Drug Development 12/18/12 Boston
Blend Therapeutics Lands $16,000,000 Series B Funding Round 12/18/12 Boston
LogMeIn, Safari, Forma, And More Behind the Boston-Area Deals News 01/11/12 Boston
Blend Therapeutics Receives $2,800,000 Series A Financing Round 01/09/12 Boston
Langer, Farokhzad Start New Combo Drug Company, Blend Therapeutics 01/06/12 Boston
Page 1 of 1